Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

XRAY LAWSUIT ALERT: Levi & Korsinsky Notifies Dentsply Sirona Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

XRAY

NEW YORK, June 30, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) of a class action securities lawsuit.

Levi & Korsinsky, LLP (PRNewsfoto/Levi & Korsinsky, LLP)

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Dentsply investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities that purchased Dentsply's common stock between June 9, 2021, and May 9, 2022. Follow the link below to get more information and be contacted by a member of our team:

https://www.zlk.com/pslra-1/dentsply-sirona-inc-loss-submission-form?prid=29345&wire=4

XRAY investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

CASE DETAILS: According to the filed complaint, defendants orchestrated a scheme to inflate Dentsply's revenue and earnings by manipulating the Company's accounting for a distributor rebate program so that senior executives would be eligible for significant cash and stock-based incentive compensation. In order to facilitate this scheme, Dentsply and its executives made numerous false and misleading statements to investors during the class period. As a result of defendants' misrepresentations, Dentsply's common stock traded at artificially inflated prices during the class period.

WHAT'S NEXT? If you suffered a loss in Dentsply during the relevant time frame, you have until August 1, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/xray-lawsuit-alert-levi--korsinsky-notifies-dentsply-sirona-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-301577963.html

SOURCE Levi & Korsinsky, LLP

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today